Use of GnRH antagonists in assisted reproduction techniques (ARTs): First report in Mexican literature;Uso de antagonistas de GnRH (Cetrorelix) en reproducción asistida: Primer informe en la literatura mexicana

Ginecologia y Obstetricia de Mexico

Volumn 70, Issue SEPT., 2002, Pages 424-430

  Ambe, Alberto Kably ^a   Ruiz, A J ^a   Baptista P, A A ^a   Serulle T, Y ^a   Quesnel G, B C ^a  

^a Hospital Ngeles de Las Lomas

Author keywords

Antagonists GnRH; Cetrorelix; ICSI; In vitro fertilization

Indexed keywords

CETRORELIX; ESTRADIOL; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; DRUG DERIVATIVE; GONADORELIN; HORMONE ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; EMBRYO TRANSFER; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; NIDATION; OOCYTE DONATION; PREGNANCY; COMPARATIVE STUDY; FEMALE; OVULATION INDUCTION;

ADULT; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OVULATION INDUCTION; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 0036719515     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Elter K, Nelson LR. Use of third generation gonadotropin releasing hormone antagonists in in vitro fertilization-embryo transfer: a review. Obstet Gynecol Surv 2001; 56: 576-88.
2. Felberbaum R, Diedrich K. Ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin releasing hormone analogues: Agonists and antagonists. Hum Reprod 1999; 14: 207-21.
3. Felberbaum RE, Albano C, Ludwig M. Ovarian stimulation for assisted reproduction with HMG and concomitant mid cycle administration of the GnRH antagonist cetrorelix according to the múltiple dosis protocol: A prospective uncontrolled phase III study. Hum Reprod 2000; 15: 1015-20.
4. Lin Y, Kahn JA, Hillensjö. Is there a difference in the function of granulose-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Hum Reprod 1999; 14: 885-8.
5. Olivennes F, Fanchin R, Bouchard P. The single or dual administration of the gonadotropin-releasing hormone antagonist cetrorelix in an in vitro fertilization embryo transfer program. Fertil Steril 1994; 62: 468-76.
6. Olivennes F, Fanchin R, Bouchard P. Scheduled administration of a gonadotrophin-releasing hormone antagonist (cetrorelix) on day 8 of in vitro fertilization cycle: A pilot study. Hum Reprod 1995; 10: 1382-6.
7. Olivennes F, Alvarez S, Bouchard P. The use of a GnRH antagonist (cetrorelix) in a single dose protocol in IVF-embryo transfer: A dose finding study of 3 versus 2 mg. Hum Reprod 1998; 13: 2411-4.
8. Albano C, Smitz J, Tournaye H. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in vitro fertilization/intracytoplasmic sperm injection cycles. Hum Reprod 1999; 14: 1426-30.
9. Albano C, Felberbaum R E, Smitz J. Ovarian stimulation with HMG: Results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH agonista buserelin. European cetrorelix study group. Hum Reprod 2000; 15: 526-31.
10. Christin-Maitre S, Olivennes F, Dubourdie S, Chabbert-Buffet N, Charbonnel B, Frydman R, Bouchard P. Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation. Clin Endocrinol 2000; 52: 721-6.
11. De Jong D, Macklon N S, Fauser B C J. A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 2000; 73: 1051-4.
12. Rongieres-Bertrand C, Olivennes F, Righini C. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (cetrorelix): A pilot study with minimal stimulation. Hum Reprod 1999; 14: 683-8.
13. Tavaniotou A, Albano C, Smitz J, Devroey P. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist cetrorelix. Hum Reprod 2001; 16: 663-7.
14. Kably A, Karchmer S, Grosso JM, Quesnel C, Barroso G. Evaluación de la penetración del medio de cultivo a la cavidad uterina como efecto del lavado cervical previo a la transferencia embrionaria: estudio prospective y observacional en piezas obtenidas por histerectom Ginec Obstet Mex 2001; 69: 375-9.
15. Kably A, Castelazo E, Vaca D, Barroso G. Transferencia embrionaria: un paso crco en reproducción asistida. Ginec Obstet Mex 2001; 69: 118-23.